Advertisement
amednews.com
BUSINESS

SEC probes backdating of stock options

Health firms are among 30 companies investigated for giving possibly illegal pay boosts to their executives.

By Bob Cook, AMNews staff. June 19, 2006.


UnitedHealth Group, whose CEO has come under scrutiny for what appears to be fortuitously timed stock options worth $1.6 billion, isn't the only health care company whose name comes up when the subject turns to so-called "backdating" of stock options.

CaremarkRx, a pharmacy benefits manager, Renal Care Group, a dialysis company, and United, the nation's second largest private health plan, are among the 30 companies publicly identified as being under investigation by the Securities and Exchange Commission or other federal authorities over how they compensated their top executives.


ADVERTISEMENT

At issue is how companies timed the awarding of options, which allow holders to buy stock at a predetermined strike price, no matter what the actual trading price. Investigators are looking into whether the companies illegally set the strike price back to the year's previous lowest stock price rather than to a preset date. That would allow executives to buy low and sell high without having to time the market themselves, thus giving them a fatter compensation.

Securities experts say backdating is not necessarily illegal. A company can backdate options if, say, such a practice was properly approved by its board and spelled out to shareholders in regulatory filings.

[...]
Full text of AMNews content is available to AMA members and paid subscribers.

Copyright 2006 American Medical Association. All rights reserved.